Medicare Enrolled

Dr. Matthew Fiesta, MD

Radiation Oncology · Fort Worth, TX
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Consulting-driven
815 PENNSYLVANIA AVE, Fort Worth, TX 76104
8173210300
In practice since 2008 (17 years)
NPI: 1316100084 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Fiesta from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Fiesta? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Fiesta

Dr. Matthew Fiesta is a radiation oncology specialist in Fort Worth, TX, with 17 years of NPI registration. Based on federal Medicare data, Dr. Fiesta performed 152 Medicare services across 128 unique beneficiaries.

Between the years covered by Open Payments, Dr. Fiesta received a total of $74,473 from 28 pharmaceutical and/or device companies across 436 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in radiation oncology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Fiesta is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 17 years in practice ▲ 152 Medicare services $74,473 industry payments

Medicare Practice Summary

Medicare Utilization ↗
152
Medicare services
Bottom 7% in TX for radiation oncology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
128
Unique beneficiaries
$96
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~9 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Ultrasonic guidance for blood vessel access 44 $11 $57
Insertion of tube into intracranial artery for diagnosis or treatment with review by radiologist 20 $180 $1,704
Insertion of tube into internal neck artery for diagnosis or treatment with review by radiologist 19 $257 $1,688
Imaging of blood vessel 19 $70 $332
Insertion of tube into brain artery for diagnosis or treatment with review by radiologist 18 $185 $1,545
Review by radiologist of image for insertion of material to block blood flow 16 $55 $263
Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes 16 $10 $50
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$74,473
Total received (2018-2024)
Avg $10,639/year across 7 years
Top 1% in TX for radiation oncology
28
Companies
436
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$54,606 (73.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$10,423 (14.0%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,443 (12.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$13,015
2023
$9,035
2022
$8,002
2021
$15,653
2020
$1,457
2019
$22,160
2018
$5,150

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Stryker Corporation
$32,161
Abbott Laboratories
$14,676
Penumbra, Inc.
$14,447
Medtronic USA, Inc.
$8,137
Balt USA, LLC
$2,149
Medtronic, Inc.
$419
Silk Road Medical, Inc.
$345
Viz.ai, Inc.
$302
Rapid Medical Ltd
$296
Imperative Care, Inc
$246
MicroVention, Inc.
$215
DePuy Synthes Sales Inc.
$213
Scientia Vascular
$162
Bard Peripheral Vascular, Inc.
$125
ShockWave Medical, Inc
$112
Medtronic Vascular, Inc.
$104
CARDIVA MEDICAL, INC.
$77
W. L. Gore & Associates, Inc.
$74
Becton, Dickinson and Company
$40
Boston Scientific Corporation
$35
AngioDynamics, Inc.
$28
Sirtex Medical Inc
$24
CORDIS US CORP.
$20
Terumo Medical Corporation
$20
Surmodics, Inc.
$16
Route 92 Medical, Inc.
$15
Biocompatibles, Inc.
$11
Terumo BCT, Inc.
$7
Top 3 companies account for 82.3% of total payments
Associated products mentioned in payments ›
8F BASE CAMP SHEATH SYSTEM · ACCULINK · ALPHAVAC · ATLAS · AXS VECTA · AXS VECTA 71 · AZUR CX DETACHABLE · Ballast · Ballast 088 Long Sheath · Benchmark · CARDIVA VASCADE 6/7F VCS · CATALYST · CONCERTOTM · Comaneci · Concerto · Covidien-Intrasaccular · ELUVIA · EMBOTRAP · EMBOTRAP II Revascularization Device · ENROUTE .014 Guidewire · ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter · ENROUTE Transcarotid Neuroprotection System · ENROUTE Transcarotid Stent · EVOLVE · EXCLUDER Conformable AAA Endoprosthesis with Active Control · Ellipsys · Emboshield NAV6 system · FLOWGATE · FRED · GORE TAG Conformable Thoracic Endoprosthesis · GORE VIABAHN Endoprosthesis with Heparin · HARVEST BMAC · HydroFrame Coil · INFINITY · IVS - VERTEBRAL AUGMENTATION PRODUCTS · JET · Jet 7 · Jet D · LVIS JUNIOR · MYNX CONTROL · NEURO · ONYX 18 · Optima Coil System · Optima Thermal Coil System · PIPELINE · POD · Penumbra Coil 400 · Penumbra Jet 7 · Penumbra SMART Coil · Penumbra System · Pipeline · Pounce Thrombectomy System · REAL System · RED 72 · Raptor Aspiration Catheter · Riptide · Rist-7F · SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER · SIR-Spheres Microspheres · SURPASS · SURPASS EVOLVE · SYNCHRO · Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter · Smart Coil · Solitaire · Supera peripheral stent system · TARGET · THERASPHERE - BIO · TIGERTRIEVER 17 REVASCULARIZATION DEVICE · TREVO · Viz.AI LVO · WEB · WEB Aneurysm Embolization System · WINGSPAN · Xact carotid stent system · ZOOM 88-T LARGE DISTAL PLATFORM · ZOOM REPERFUSION CATHETER
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (73%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 1% for radiation oncology in TX.

Equivalent to $48,995 per 100 Medicare services performed
Looking for a radiation oncology specialist in Fort Worth?
Compare radiation oncologists in the Fort Worth area by procedure volume, costs, and industry payment transparency.
Browse radiation oncologists nearby

Geographic Context

Radiation oncologists within 10 mi
243
Per 100K population
11.4
County median income
$81,905
Nearest hospital
JPS HEALTH NETWORK
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Fiesta is a mixed practice specialist, with moderate Medicare volume, with consulting-driven industry engagement in the top 1% of TX peers, with 17 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Fiesta experienced with ultrasonic guidance for blood vessel access?
Based on Medicare claims data, Dr. Fiesta performed 44 ultrasonic guidance for blood vessel access services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Fiesta receive payments from pharmaceutical companies?
Yes. Dr. Fiesta received a total of $74,473 from 28 companies across 436 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Fiesta's costs compare to other radiation oncologists in Fort Worth?
Dr. Fiesta's average Medicare payment per service is $96. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Fiesta) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →